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SUMMARY
We all hope that biotechnology will answer some social and economical unavoidable requirements of the modern life. It is
necessary to improve agriculture production, food abundance and health quality in a sustainable development. It is indeed a hard task
to keep the progress on taking into account the rational use of genetic resources and the conservation of biodiversity. In this context,
a historical perspective and prospects of the biomedical research on parasitic diseases is described in a view of three generations of
investigators. This work begins with a picture of the scientific progress on biomedical research and human health over the last
centuries. This black-and-white picture is painted by dissecting current advancements of molecular biology and modern genetics,
which are outlined at the meaning of prospecting achievements in health science for this new millenium.
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Public health achievements and biomedical research on the last
centuries: Progresses of medicine and public health were lever up at the
middle of 19th century as a consequence of the industrial revolution.
Arm workers were the functional parts of the capitalism machinery. The
wear and tear of these parts was a concern for the industrial productivity.
Moreover, epidemic diseases were spreading over the overgrowing cities,
reaching the dominant classes28.
There was no way to recognize the diseases and their etiologies.
Scientists believed air and water pollution was related to ailments32.
Overcrowding cities and sanitary deprivation were adjuvants for
dissemination of infectious diseases. Due to this situation, investments
on public health became obviously necessary.
Strict state’s sanitary inspection orders were evacuate and demolish
the slum tenements, as a way of “cleaning the cities”. Urban peripheries
raised together with the misunderstanding and dissatisfaction of the
citizens. Oswaldo Cruz, for instance, was a target of social reaction while
controlling yellow fever. Actually, he became a victim of governmental
imposition. Naturally, benefits of his work were recognized and today
Oswaldo Cruz is considered one of the greatest sanitarian of that century31.
The end of the 19th century was marked by statistical measurements.
Health was measured in terms of statistical indexes correlated with
biological and socioeconomical parameters. At least, these data have
revealed the social disparities in health. The epidemiology appeared as a
science searching for factors, in a meta and multi analysis, which could
determine the presence of diseases. Therefore, epidemiology and statistics
have contributed to predict, control and interfere in diseases.
At this period, the microbial theory of diseases became evident due
to advancements on microscopy and microbiology. In this context, Brazil
was the main scenario for the birth of the tropical medicine supported
by the interest of scientific European community and the presence of a
competent technical staff for the development of health technology. The
Oswaldo Cruz Institute was known as the pioneer research center where
brilliant scientists, such as Oswaldo Cruz, Vital Brasil and Carlos Chagas
contributed to tropical medicine.
New drugs, antibiotics, vaccines and technologies were developed
at the middle of 20th century. A work plan on disease control could be
established for diseases such as malaria, syphilis, tuberculoses, leprosy,
diphtheria, polio, measles, tetanus and whooping cough. The vaccination
has covered 80% of the population as an attempt to eradicate some of
these diseases7. This fact was accomplished by massive delivering of
pure drinking water, sewage and garbage disposal. Moreover, scientific
discoveries have alerted people about behaviors which were harmful for
their health.
Since 1930-40, as a result of social pressure in an economical crisis
postwar, Brazil has been experiencing the raising of institutional social
securities and rights for all levels of employees, such as medical assistance,
pensions, retirement and others. The result is the reduction of child
mortality, infectious diseases, and the increment of the expectation of life.
However, the index of mortality caused by infectious diseases is 33/100,000
habitants39. This high rate is due to poverty and absence of health conditions
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for millions of people. The lack of uniform revenue distribution transforms
our country in one of the most social disparities in the world. Poverty,
uncontrolled human migrations, ecological disasters, absence of urban
infrastructure and decrement of life quality make difficult to control and
eradicate some diseases such as tuberculosis, intestinal parasitoses, dengue,
malaria, Chagas disease, schistosomiasis. In this field, the science has
reached its objective, it is time to political decisions.
Biological sciences can still contribute to elucidate the mechanisms
of parasite survival and virulence. There was no vaccine for all pathogens.
New pathogens and some examples of conventional drug resistance
parasite strains imply continuos investigation. In fact, refinement of such
technologies for investigation is necessary to go further on the
comprehension of the biology of parasite and host-parasite interactions.
The biotechnology appears as a promise for the comprehension of such
mechanisms at the basis of elucidating genetic information and
developing new tools for disease intervention.
Parasitic diseases and the biotechnology: Several species are
competing for surviving in a rich planet where the resources are variable
but limited. Species can share resources but they can rarely occupy the
same ecological niche. This fact creates a disharmonic relationship and
sometimes leads to competitive exclusion. Parasitism is an ecological
relationship among different species, almost always disharmonic.
However, evolution plays its role over the natural history whenever is
possible: the coexistence of different species.
A parasite must present peculiar adaptation since the host organism
is its environment. Blood, gastrointestinal or genitourinary tracts seem
to be, at first sight, complex and aggressive environments. Once again,
evolution takes place, modeling the parasites good experts on evading
or even taking advantage of such condition.
Genome modification is the main result of evolution. Coevolution
of host and parasite results in modification of both genomes in attempt
for reproduction and surviving. Genetic variability is the molecular basis
for understanding some intriguing facts, such as host resistance, parasite
virulence, acquired drug resistance and immune evasion. For this reason,
genome sequencing projects can provide real and valuable information.
Therefore, current development of immunogenetics, molecular
biology and modern genetics has opened new possibilities for the human
health. The biotechnology could be defined as the rational use of this
knowledge and tools to give us the answers which are necessary for
intervening in a biological process, such as a disease.
Accessing the genome information: There are several evidences
that genetic factors play a role in determining susceptibility to many
infectious diseases. Initially, alleles from the major histocompatibility
complex were recognized to be implicated in this process35,36. The
identification of such alleles can be limited to a specific human
population. The geographical heterogeneity is related to some intrinsic
variables, such as genetic variation of the parasite antigens. The reverse
immunogenetics has permitted the characterization of the T cell epitope
associated with this polymorphism4,9.
Nowadays, we know that several non-MHC genes can also play a
role in pathogenicity of genetic and infectious diseases. Familial studies
have indicated that “background” genes may be implicated in diseases37.
The complete comprehension of a pathology may help to preview
candidate gene polymorphism. For example, approximately twelve genes
related to malaria susceptibility in certain human populations were
described15. Sometimes, a candidate gene approach is not feasible. In
that case, the development of microsatelite markers has revolutionized
the genetic linkage studies. Hundreds of microsatelites are dispersed in
intervals of 10cM or 10 megabases. It is possible to follow the segregation
of markers in a familial study. The sharing of a genetic marker among
slibings affected by the disease indicates that the marker cosegregates
with the susceptibility gene27. Further intensive work is necessary to
reach the fine mapping of the gene.
There are some molecular techniques which allow the genetic
discrimination of individuals belonging to the same specie. In one hand,
this will lead us to think about our specie concepts, on the other hand,
these techniques are successfully being taken in studies of molecular
epidemiology24. Characterization of rDNA sequences and their non-
transcribed spacers is being used to discriminate parasite isolates16,17.
Random amplification of polymorphic DNA (RAPD) is achieved by a
low-stringent PCR with short and arbitrary oligonucleotides as the primers
of reaction. RAPD is usually performed with several arbitrary primers.
Each RAPD reaction usually leads to multiloci analysis. Efforts are being
spent for the development of parasite genome microsatelite markers34.
 Moving from putative loci or candidate genes to the right gene(s)
responsible for the disease can take time and several studies with different
populations. Identification of expressed sequence tags (EST) and their
chromosomal locations (transcript map) in human genome projects, for
instance, will speed up this step1.
The current modern genetics is producing genetic maps, physical
maps and complete nucleotide sequences18. Nowadays, DNA sequencing
projects have provided the complete genomic sequences of 141 viruses,
51 organelles, two eubacteria, one archeon, and one eukaryote
(Sacharomyces cerevisiae). Among genome projects, it has been
announced the first, almost complete, sequencing of the human genome30.
There are some genome projects of human parasites in progress, mostly
Plasmodium, trypanosomatids and Schistosoma2,40. The next step is to
understand the functional genome which tries to explain how hundred
thousands of genes control the organism’s life in response to the
environment resulting in genetic variability.
Because of our accumulative knowledge in this area together with
the rapidly development of robotics and bioinformatics, the biological
research is entering in a genomic era. The high-throughput sequencing
will soon provide a whole view of a new biological scenario. The biome
could be considered a compilation of three complementary parts: genome,
transcriptome and proteome. Functional genomes will provide the linking
of genetic variability and phenotype of organisms. The importance of
that becomes evident since all physiological and pathological processes
are results of gene expression.
Two-dimensional electrophoresis of proteins creates reproducible
proteomic maps. Nowadays, individual protein spots can be
unambiguously identified using MALDI-TOF10. In addition, several
methodologies are available for analysis of differential gene expression
at the level of genes and their first products37. Single and double nucleic
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acid strands can be physical-chemically separated by hydroxyapatite
chromatography6. It is possible to subtract differential DNA sequences
in a comparative study. The DNA subtraction methodology coupled with
PCR has gained sensibility12,21. The differential display of mRNA allows
the comparative analysis of several transcripts at the same time, using
combination of an oligo-dT anchored primer and arbitrary primers in a
reverse transcriptase PCR approach19. Normalization of cDNA libraries
has increased the chance of detection of very poor expressed genes,
since it almost equalizes the relative quantity of cDNA molecules3,33.
Currently, the DNA microarray (DNA chip) represents the most
promising biotechnological tool for the analysis of functional genome.
An array of several known DNA sequences is linked onto a small glass
surface. Two DNA populations are labeled with different fluorochromes.
Comparative hybridization can be performed in this DNA matrix
simultaneously. Upon hybridization, the DNA chip is scanned in attempt
to detect epifluorescence spots. The automated analysis distinguishes
differences of hybridization of even 2 fold approximately8,22,26. The DNA
chip requires a very small area, which means reduction of the volume of
hybridization with consequent higher probe concentration and sensitivity.
Robotic technology can design large-scale and high-density microarrays.
Thus, thousands of sequences can be quickly screened at once by using
automated procedures26.
In fact, DNA microarray is a high-throughput technology for gene
expression analysis, which allows the monitoring of genes related to
tissue specificity, biochemical pathways, pathogenesis, drug effects, drug
metabolism and any other cellular stress5,14,29. Moreover, it is a rapid
approach for detecting mutations in human disease genes, mapping
disease genes by linkage analysis and discovering novel gene
polymorphisms11,20,41.
Prospects for the biomedical research at this new millenium: The
employment of these sophisticated biotechniques can provide further
advancements of the biomedical science. Investigators are able to sequence
a genome of any specie theoretically. The linear DNA sequence must be
organized to give information about the genome organization, potential
opening reading frames, intergenic sequences. Homology comparisons
must be explored to reveal gene functions and protein modeling. The genes
and related sequences could be catalogued in aspects of their functions
such as cell metabolism, division, growth. In case of parasite genomes we
could find genetic determinants of virulence, vaccine candidate, drug and
diagnostic targets. For this reason, we understand bioinformatics as a
necessary and powerful tool which can lead to interpretation and
organization of sequence data generated by the study of the biome.
We consider that the coupling of genome projects with expression
analysis would be the great advancement of the biomedical research in a
brief future. It will be continuously necessary to decode genomes but
also to give functions for the new sequences. This will answer the whole
function of a living parasite, how it becomes a pathogen. Other intriguing
aspects will be elucidated, such as the role of genetic polymorphism in
host adaptation, parasite virulence and drug resistance.
The comprehension of pathological events at molecular level and
the characterization of these particular genes and polymorphisms will
provide us a way for intervention. Once it may be possible to identify
genetic risk groups and virulent parasite strains, specific preventive or
therapeutic intervention could be targeted. In addition, there are several
unknown genes which are fundamental for parasite surviving, others
can possess specific epitopes that whenever displayed result in protective
immunological response. These gene products must be good candidates
for drug design and vaccines. Comparative studies of genomes will reveal
the biodiversity of parasites and their phylogenetic relationship.
Genetic markers are being taken in diagnosis of several
pathogens13,23,25. Molecular diagnosis will be soon a medical practice
worldwide for a large range of parasitic and genetic disorders. Several
diseases can share symptoms which complicates an accurate diagnosis,
even with clinical suspicion. Molecular diagnosis will be a medical tool
for a sensible and precise diagnosis diminishing the suffering of patients.
Genetic markers will indicate predisposition for some diseases
prospecting the appearance of genetic disorder in a period of life. Thus,
genetic predisposition diseases such as cancer, cardiovascular disorders
and Alzheimer could be warned out early allowing individual prevention
through behavior aspects and routine medical exams.
In summary, current achievements of molecular genetics and the
development of bioinformatics are creating fantastic tools for the
biomedical research, prospecting new scientific discoveries. Among
ethical and biosecurity aspects, the biotechnology must be considered
as the rational utilization of this knowledge and tools in taking benefits
for the humanity, producing food and providing health quality. In this
new millenium, the improvement of human life through the use of
biotechnology appears to be a real promise to deal with overcrowding
world, scarce of genetic resources and life quality in a sustainable
development.
RESUMO
Uma perspectiva histórica e prospecções da pesquisa biomédica
em doenças parasitárias
Espera-se que os grandes avanços da pesquisa de genomas alcancem
saltos visíveis para a sobrevivência da humanidade dentro do contexto
de sustentabilidade global. Vemos atualmente a necessidade imediata de
incrementar a produção de alimentos e melhorar a qualidade de vida e
saúde humana, mantendo a biodiversidade preservada. A biotecnologia
é a utilização racional das ferramentas geradas pela biologia molecular e
genética moderna que, dado ao grande avanço dessas áreas, poderá em
breve responder essas novas questões. Este trabalho, escrito por três
gerações de pesquisadores, inicia com uma perspectiva histórica da
pesquisa biomédica em doenças parasitárias nos últimos séculos em nosso
país. Em seguida, descrevemos os mais recentes avanços da biologia
molecular e genética genômica. Ressaltamos a importância dessas novas
conquistas dentro de uma prospecção da pesquisa biomédica deste século
e seus possíveis impactos na saúde humana.
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